UBS AM’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $110M | Sell |
|
|||||
|
2025
Q2 | $147M | Buy |
|
|||||
|
2025
Q1 | $88.7M | Buy |
|
|||||
|
2024
Q4 | $66.9M | Sell |
|
|||||
|
2024
Q3 | $84.1M | Buy |
|
|||||
|
2024
Q2 | $73.8M | Buy |
|
|||||
|
2024
Q1 | $56.6M | Buy |
|
|||||
|
2023
Q4 | $41.7M | Buy |
|
|||||
|
2023
Q3 | $36.5M | Buy |
|
|||||
|
2023
Q2 | $41.7M | Hold |
|
|||||
|
2023
Q1 | $41.7M | Buy |
|
|||||
|
2022
Q4 | $43.1M | Buy |
|
|||||
|
2022
Q3 | $41.4M | Buy |
|
|||||
|
2022
Q2 | $39.4M | Sell |
|
|||||
|
2022
Q1 | $36.6M | Buy |
|
|||||
|
2021
Q4 | $36.5M | Buy |
|
|||||
|
2021
Q3 | $21.3M | Buy |
|
|||||
|
2021
Q2 | $23.5M | Buy |
|
|||||
|
2021
Q1 | $22.6M | Buy |
|